Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: Potential role for interleukin-6
 
  • Details

Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: Potential role for interleukin-6

Journal
Atherosclerosis
Journal Volume
158
Journal Issue
2
Pages
471
Date Issued
2001
Author(s)
Lee T.-M.
Su S.-F.
HWANG, JUEY-JEN  
Tseng C.-D.
MING-FONG CHEN  
Lee Y.-T.
SHOEI-SHEN WANG  
DOI
10.1016/S0021-9150(01)00457-9
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034813229&doi=10.1016%2fS0021-9150%2801%2900457-9&partnerID=40&md5=a8c7722d32a96bc7671dea711f1991fa
https://scholars.lib.ntu.edu.tw/handle/123456789/471173
http://ntur.lib.ntu.edu.tw//handle/246246/95146
Abstract
Cilostazol, a novel oral phosphodiesterase inhibitor, has shown consistent improvement in exercise tolerance in patients with intermittent claudication (IC). In addition to this effect, cilostazol has previously been shown to have beneficial effects on the dyslipidemia, i.e., combination of high triglycerides with low high-density-lipoprotein cholesterol (HDL-C) levels. Interluekin-6 (IL-6) suppresses the activity of lipoprotein lipase, which modulates the metabolism of triglycerides and HDL-C. To determine whether a reduction of IL-6 contributes to the improvement of lipid profiles, we prospectively investigated the effect of cilostazol (n=16, 100 mg, twice daily) on the changes of lipid profiles and on the association with the changes of IL-6 compared with those of pentoxifylline (n=16, 400 mg, bid) in patients with IC. After eight weeks of administration of cilostazol to patients with IC, walking distances were increased, associated with a 29% decrease in plasma triglycerides and a 13% increase in HDL-C. No significant changes of lipid profiles in the pentoxifylline and placebo groups were observed although a similar improvement in walking distances was achieved in the pentoxifylline group. IL-6 levels were significantly reduced in patients receiving cilostazol as compared with those receiving placebo or pentoxifylline. The cilostazol-induced changes in the IL-6 were positively related to those of triglycerides in the cilostazol group (r=0.63, P<0.05) and negatively related to those of HDL-C (r=-0.55, P<0.05). These findings suggest that in addition to consistent improvement of exercise tolerance, cilostazol may improve lipid profiles by reducing IL-6 release. However, pentoxifylline did not affect lipid profiles although a similar improvement of maximal walking distance (MWD) was achieved. ? 2001 Elsevier Science Ireland Ltd. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
cilostazol; high density lipoprotein cholesterol; interleukin 6; lipid; pentoxifylline; placebo; triacylglycerol; adult; aged; article; cholesterol blood level; clinical article; clinical trial; controlled clinical trial; controlled study; cytokine release; dose time effect relation; double blind procedure; drug effect; drug potency; exercise tolerance; female; human; intermittent claudication; lipogenesis; male; peripheral occlusive artery disease; priority journal; protein blood level; randomized controlled trial; treadmill exercise; treatment outcome; triacylglycerol blood level; walking; Aged; Antilipemic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Interleukin-6; Intermittent Claudication; Lipids; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Tetrazoles; Triglycerides; Vasodilator Agents
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science